The epidemiology of HIV infection in edinburgh related to the injecting of drugs: An historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum

Journal of Infection

Volumn 32, Issue 1, 1996, Pages 53-62

  Burns, Sheila M ^a   Brettle, Raymond P ^a   Gore, Sheila M ^b   Peutherer, John F ^c   Robertson, J Roy ^d  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d West Granton Medical Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD ANALYSIS; DRUG USE; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; SEROCONVERSION; VIRUS INFECTIVITY;

ADULT; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; MALE; NEEDLE SHARING; RETROSPECTIVE STUDIES; SCOTLAND; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 0029872875     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(96)80010-7     Document Type: Article

References (54)

1. Gossop M. Living with Drugs. London: Temple Smith, 1982.
2. Pearson G, Gilman M, McIver S. Young people and heroin: an examination of heroin use in the North of England. Health Education Council, Research Report No: 8; November 1985,
3. Robertson JR. Drug users in contact with general practice. Br Med J 1985; 290: 34-35.
4. Robertson JR, Skidmore CA, Roberts JJK, The dynamics of an illicit drug scene. Scot Med J 1988; 33: 293.
5. Brettle RP, Nelles B. Special problems of injecting drug misusers. Br Med Bull 1988; 44: 149-160.
6. Haw S, Liddle D. Drug problems in Edinburgh District. Report of the SCODA Fieldwork Surrey. SCODA 1-4 Hatton Place, London EC1N 8ND.
7. Robertson JR, Bucknall ABV, Welsby PD et al. An epidemic of AIDS-related virus (HTLV-III/LAV) infection amongst intravenous drug abusers in a Scottish general practice. Br Med J 1986; 292; 527-530.
8. Report of the Advisory Council on the Misuse of Drugs. Treatment and Rehabilitation DSS, London 1982.
9. Department of Health Working Party. Guidelines on Good Clinical Management: The Management of Drug Users, HMSO, London 1984.
10. Advisory Council on the Misuse of Drugs. AIDS and Drug Misuse: Part 1. Department of Health and Social Security, Her Majesty's Stationery Office, London, 1988.
11. Ritson AB and Plant MA. Drugs and young people in Scotland. Scottish Health Education Unit, Edinburgh 1977.
12. Robertson JR, Bucknall AB. Heroin users in a Scottish City. Edinburgh Drug Addiction Study, West Granton Medical Group, 1 Muirhouse Avenue, Edinburgh, EH4 4PL, 1986.
13. Waldorf D, Biernachie PJ. Natural recovery from heroin addiction: a review of the incidence literature. Drug Issues 1979; 9: 281-289.
14. Wille R. Processes of recovery from heroin dependence: relationship to treatment social change and dry use. Drug Issues 1983; 13: 333-342.
15. Statement from the Pharmaceutical Society's Council: Sale of hypodermic syringes and needles. Pharm 1986; 15: 205.
16. National Pharmaceutical Association. The dilemma - drug addicts and AIDS. The Supplement 1986; 1-2: 690.
17. Robertson JR. The Edinburgh epidemic: a case study In: Strang J, Stimson G (eds) AIDS and Drug Misuse. London and New York: Routledge, 1990.
18. Brettle RP, Flegg P, MacCallum L. Injection drug use related HIV and AIDS. In: Harris W, Forster S (eds) Recent advances in STD and AIDS (4) London: Churchill Livingstone, 1991; 91-128.
19. Brettle RP, Bisset K, Burns SM et al. Human immunodeficiency virus and drug misuse - The Edinburgh experience. Br Med J 1987; 295: 421-424.
20. Peutherer JF, Edmond E, Simmonds P, Dickson JD, Bath GE. HTLV-III antibody in Edinburgh drug addicts. Lancet 1985; ii: 1129-1130.
21. Robertson JR, Bucknall ABV, Wiggins P. Regional variations in HIV antibody seropositivity in British intravenous drug users. Lancet 1986; i: 1435-1436.
22. Urquhart GED, Scott SS, Wooldridge E et al. Human Immunodeficiency Virus (HIV) in intravenous drug abusers in Tayside. Communicable Diseases Scotland (Weekly Report) 1987; 89/09: 5-10.
23. Brunet J-B, Des Jarlais DC, Koch MA. Report on the European Workshop on Epidemiology of HIV infections: Spread among intravenous drug abusers and the heterosexual population. AIDS 1987; 1: 59-61.
24. Des Jarlais DC, Friedman SR, Stoneburner RL. HIV infection and intravenous drug use: Criticial issues in transmission dynamics, infection outcomes and prevention. Rev Infect Dis 1988; 10: 151-158.
25. Bisset C, Jones G, Davidson J et al. Mobility of injection drug users and transmission of HIV. Lancet 1989; ii: 44.
26. Franceschi S, Tirelli U, Vaccher E et al. Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US Military Base. Lancet 1986; i: 804.
27. Sarkar S, Mookerjee P, Roy A et al. Descriptive epidemiology of intravenous heroin users - a new risk group for transmission of HIV in India.
28. Brettle RP, McNeil AJ, Gore SM, Bird AG, Leen CSL, Richardson A. Analysis of enrolment, progression, survival, mortality and baseline covariates in the Edinburgh City Hospital Cohort. QJM 1995 (in press).
29. CD4 Collaborative Group. Use of monitored CD4 counts: predictions of the AIDS epidemic in Scotland. AIDS 1992; 6: 213-222.
30. Report of a working group convened by the Chief Medical Officer for Scotland (Chairman: Dr DBL McClelland) Acquired Immune Deficiency Syndrome in Scotland - projections to the end of 1992. Scottish Home and Health Department, Edinburgh 1990.
31. Report of working group (Chairman: Professor NE Day). The incidence and prevalence of AIDS and other severe HIV disease in England and Wales for 1992-1997: projections using data to the end of June 1992. Communicable Disease Report 1993; 3(Suppl 1): S1-S17.
32. Report of a Working Group convened by the Chief Medical Officer for Scotland (Chairman: Dr D Reid). Acquired Immune Deficiency Syndrome and HIV-related disease in Scotland. Communicable Diseases (Scotland) Unit, Glasgow 1993.
33. McNeil AJ, Brettle RP, Burns SM, Gore SM. Bird AG, Richardson A. Ten year follow-up analysis of the Edinburgh City Hospital seroconverters. Br Med J 1994.
34. McNeil AJ. Statistical methods in AIDS progression studies with an analysis of the Edinburgh City Hospital Cohort PhD Thesis, Cambridge University 1993.
35. Raab GM, Gore SM, Goldberg DJ, Donnelly CA. Bayesian forecasting of the HIV epidemic in Scotland. J R Stat Soc Series A 1994; 157: 17-30.
36. Bacchetti P. Estimating the incubation period of AIDS by comparing population infection and diagnosis patterns. J Am Stat Assoc 1990; 85: 1002-1008.
37. Turnbull BW. The empirical distribution function with abritrarily grouped, censored and truncated data. J R Stat Soc Series B 1976; 39: 290-295.
38. Ronald PJM, Robertson JR, Wyld R, Weightman R. Heterosexual transmission of HIV in injecting drug users. Br Med J 1993; 307: 1184-1185.
39. Gore SM, Bird AG. No escape: HIV transmission in jail. Prisons need protocols for HIV outbreaks. Br Med J 1993; 307: 147-148 and 681.
40. Christie B. HIV outbreak investigated in Scottish jail. Br Med J 1993; 307: 151-152.
41. Burns SM, Collacott IA, Hargreaves FD, Inglis JM. Incidence of Hepatitis B markers in HIV seropositive and seronegative drug mususers in the Edinburgh area. Communicable Diseases Scotland (Weekly Report) 1987; 87/08: 7-8.
42. Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990-92. Communicable Disease Report 1993; 3: R1-R11.
43. Raimondo G, Smedile A, Gallo L, Balbo A, Ponzerto A, Rizzetto M. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet 1982; i: 249-251.
44. Shattock AG. Morgan BM, Peutherer J, Inglis JM, Fielding JF, Kelly MG. High incidence of delta antigen in serum. Lancet 1983; 2: 104-105.
45. Bisset, C, Jones G, Davison J, Cummins B, Burns S, Inglis JM, Brettle RP. (Letter) Mobility of injection drug users and Transmission of HIV. Lancet 1989; 2: 44.
46. Novick D, Kreek MJ, Des Jarlais DC et al. Abstract of clinical research findings: Therapeutic and historical aspects. In: Problems of drug dependence (Proceedings of the 47th Annual Scientific Meeting, the Committee on Problems of Drug Dependence). NIDA Research Monograph 67, Washington DC 1985.
47. Lazzarin A, Crocchiolo P, Galli M et al. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts. Bollettino Dell Instituto Sieroterapico Milanese 1986; 66: 9-13.
48. Shattock AG, Kaminski GZ, Hillary IB. HTLV III serology, AIDS and ARC cases in Ireland. II International Conference on AIDS: Paris, France June 1986; Abstract 143.
49. Blix O, Grönbladh L. AIDS and IV heroin addicts: the preventive effect of methadone maintenance in Sweden. IV International Conference on AIDS: Stockholm, Sweden 13-16 June 1988; Abstract 8548.
50. Marmor M, Des Jarlais DC, Cohen H et al. Risk factors for infection with Human Immunodeficiency Virus among intravenous drug abusers in New York City. AIDS 1987; 1: 39-44.
51. Spira TJ, De Jarlais DC, Marmor M et al. Prevalence of antibody to lymphadenopathy associated virus among drug detoxification patients in New York. N Eng J Med 1984; 313: 467-468.
52. Des Jarlais D, Freidman SR, Choopanya V, Ward TP. International epidemiology of HIV and AIDS among injection drug users. AIDS 1992; 6: 1053-1068.
53. Robertson JR, Skidmore CA, Roberts JJK. HIV infection in intravenous drug users: a follow-up study indicating changes in risk taking behaviour. Br J Addiction 1988; 83: 387-391.
54. Fielding KL, Brettle RP, Gore SM et al. Hetrosexual transmission of HIV analysed by generalized estimating equations. Statistics in Medicine 1995; 14: 1365-78.